Advancing new drug therapies for unmet medical needs

Developing novel drug therapies for unmet medical needs 2018-11-14T18:17:53+00:00

The Dimerix Limited Clinical Trials – ACTION for Diabetic Kidney Disease and ACTION for Focal Segmental Glomerulosclerosis – Are Now Open!

Click Here For More Information

Dimerix Limited is a clinical stage biotechnology company that is listed on the Australian Stock Exchange (ASX:DXB)

Our vision is to positively improve human health by creating safe and effective new treatments for patients with unmet medical needs

Recent news and media

2018 CEO’s AGM presentation – investor call recording

Dr Nina Webster, CEO of Dimerix, presented to shareholders at the 2018 AGM where she provided a review of key highlights [...]

Click here to view analyst coverage
Click here to view our corporate fact sheet
Click here to view our corporate presentation